444 completed. 444 Phase 1, 144 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 444 | Completed 444 |
| Phase 2 | 144 | Completed 144 |
Follow Pneumonia: new trials by email Literature Review of Pneumonia trials Research Report on Pneumonia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of How Ibuzatrelvir is Taken up Into the Blood of Healthy Adults After Taking Different Tablets of Ibuzatrelvir Ibuzatrelvir co-process API film coated tablet, Ibuzatrelvir filmcoated tablet - Coronavirus Disease 2019, Coronavirus Disease 2019 (COVID-19) | Phase 1 | Completed | Pfizer | 17 | 2026-04-13 | 2026-07-28 |
| Safety and Immunogenicity Trial of PepGNP-COVID19 Vaccine in Adults PepGNP-COVID19, Sterile Water for Injection - COVID-19 | Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 60 | 2026-02-02 | 2026-10-30 |
| A Study to Learn How the Study Medicine Called Ibuzatrelvir is Taken up Into the Blood in Healthy Chinese Adults Ibuzatrelvir - Healthy Participant | Phase 1 | Completed | Pfizer | 12 | 2025-10-16 | 2026-01-07 |
| A Trial to Evaluate the Safety and Immune Response of an Investigational Pneumococcal Vaccine in Adults 50 To 64 Years of Age Pn-MAPS30plus, PCV20 - Pneumonia, Bacterial | Phase 1 | Completed | GlaxoSmithKline | 127 | 2025-08-12 | 2026-06-05 |
| Safety, Reactogenicity, and Immunogenicity Trial of STX-S SARS-CoV-2 Vaccine in Adults STX-S - COVID-19 | Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 60 | 2025-08-11 | 2026-06-26 |
| Phase 1 Study on Bioavailability, Food Effect, and Drug-Drug Interaction of ALG-097558 Tablets in Healthy Volunteers ALG-097558, Dabigatran, Itraconazole - COVID-19 | Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 51 | 2025-05-13 | 2026-05-18 |
| Phase I Single-blind Clinical Trial to Evaluate the Safety and Local Immune Activation of a Toll-like Receptor 5 Agonist (FLAMOD) Administered by Aerosol FLAMOD, Placebo - Pneumonia | Phase 1 | Completed | Institut National de la Santé Et de la Recherche Médicale, France | 46 | 2025-04-14 | 2026-04-21 |
| EFFICACY OF COLCHICINE IN IMPROVING CLINICAL OUTCOMES IN PATIENTS WITH MILD TO MODERATE COVID-19 PNEUMONIA IN LAHORE: A RANDOMIZED CONTROL TRIAL Colchicine 0.5 MG Oral Tablet - COVID - 19 | Phase 1 / Phase 2 | Completed | Zaeema Kanwal | 66 | 2025-02-24 | 2025-09-04 |
| A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of ALG-097558 in Subjects With Renal Impairment and in Healthy Subjects With Normal Renal Function ALG-097558 - COVID 19 | Phase 1 | Completed | Aligos Therapeutics | 12 | 2025-02-20 | 2026-08-25 |
| A Study to Learn About How the Flu and COVID-19 Vaccines Act in Healthy People Investigational Influenza Vaccine, Investigational COVID-19 Vaccine, Investigational Influenza and COVID-19 Combination Vaccine - Influenza, COVID-19 (Coronavirus Disease 2019) | Phase 1 / Phase 2 | Completed | BioNTech SE | 2650 | 2025-02-10 | 2026-01-26 |
| The Safety and Antibody Response of the Nasal COV2 Vaccine Against the SARS-CoV-2 Virus COVID-19 vaccine, low dose level, COVID-19 vaccine, high dose level, Nasal Drops - COVID19, Sars-Cov-2 | Phase 1 | Completed | Rokote Laboratories Finland Oy | 40 | 2025-01-21 | 2025-12-08 |
| A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of ALG-097558 in Subjects With Hepatic Impairment and in Healthy Subjects With Normal Hepatic Function ALG-097558 - COVID-19 | Phase 1 | Completed | Aligos Therapeutics | 16 | 2025-01-13 | 2026-08-05 |
| A Drug-drug Interaction Study of S-892216 Coadministered With Carbamazepime to Healthy Adult Participants S-892216, Carbamazepine - COVID-19 | Phase 1 | Completed | Shionogi | 16 | 2024-12-17 | 2025-03-11 |
| A Study to Learn About if the Study Medicine Called Ibuzatrelvir Changes How the Body Process the Other Medicine Dabigatran Etexilate in Healthy Adults Treatment B, Treatment A - SARS-CoV-2 Infections | Phase 1 | Completed | Pfizer | 20 | 2024-11-22 | 2025-01-24 |
| A Study to Learn About Flu and COVID-19 Vaccine Responses in Healthy People Investigational Influenza Vaccine, COVID-19 Vaccine, Investigational Influenza/COVID-19 Vaccine - Influenza,Human, COVID-19 | Phase 1 / Phase 2 | Completed | BioNTech SE | 1353 | 2024-11-11 | 2026-08-19 |
| A Study of an Investigational Flu Seasonal/SARS-CoV-2 Combination Vaccine in Adults Flu Seasonal /SARS-CoV-2 mRNA Dose 1, Flu Seasonal /SARS-CoV-2 mRNA Dose 2, Flu Seasonal mRNA - COVID-19 | Phase 1 | Completed | GlaxoSmithKline | 106 | 2024-11-11 | 2025-09-11 |
| A First in Human Study to Evaluate the Safety and Immunogenicity of RBM-001 in Healthy Adult Volunteers RBM-001 - COVID-19 | Phase 1 | Completed | Rock BioMedical, Inc. | 60 | 2024-09-30 | 2026-09-02 |
| A Study to Learn How Renal Impairment Affects the Pharmacokinetics of PF-07817883. PF-07817883 - COVID-19 | Phase 1 | Completed | Pfizer | 16 | 2024-09-10 | 2025-02-19 |
| Study of Gamma PN3 in the Elderly Gamma PN3, Prevnar - Pneumonia, Pneumococcal | Phase 1 | Completed | GPN Vaccines | 105 | 2024-08-26 | 2025-05-11 |
| PA-001 Ph.1 Study in Healthy and Elderly Subjects PA-001 - COVID - 19 | Phase 1 | Completed | PeptiDream Inc. | 47 | 2024-07-30 | 2026-04-09 |
Showing 20 of 444. Sign in to see all of them.
COVID-19 (381) · Coronavirus Infections (57) · Severe Acute Respiratory Syndrome (19) · Respiratory Distress Syndrome (16) · Virus Diseases (13) · Acquired Immunodeficiency Syndrome (8) · Pneumonia, Pneumococcal (8) · HIV Infections (7) · Pneumococcal Infections (7) · Pneumonia, Pneumocystis (7) · Pneumonia, Ventilator-Associated (7) · Pneumonia, Viral (7) · Acute Lung Injury (6) · Respiratory Tract Infections (6)
Respiratory Tract Diseases (442) · Lung Diseases (440) · Infections (439) · Respiratory Tract Infections (438) · RNA Virus Infections (388) · Coronaviridae Infections (383) · Nidovirales Infections (383) · Virus Diseases (378) · Pneumonia, Viral (376) · Coronavirus Infections (326) · Pathological Conditions, Signs and Symptoms (41) · Pathologic Processes (35) · Bacterial Infections and Mycoses (28) · Respiration Disorders (24)
Sodium Chloride (16) · Saline Solution (13) · nirmatrelvir and ritonavir drug combination (9) · Ritonavir (8) · Standard of Care (8) · Ivermectin (7) · 2019-nCoV Vaccine mRNA-1273 (6) · nirmatrelvir (6) · COVID-19 Serotherapy (5) · COVID-19 Vaccines (5) · ChAdOx1 nCoV-19 (5) · Injections (5) · Midazolam (5) · 23-valent pneumococcal capsular polysaccharide vaccine (4) · BNT162 Vaccine (4)
Pfizer (22) · National Institute of Allergy and Infectious Diseases (NIAID) (15) · AstraZeneca (9) · GlaxoSmithKline (7) · BioNTech SE (6) · Regeneron Pharmaceuticals (5) · CanSino Biologics Inc. (4) · Aligos Therapeutics (3) · Ampio Pharmaceuticals. Inc. (3) · AnGes, Inc. (3) · Brii Biosciences Limited (3) · Cellid Co., Ltd. (3) · Celltrion (3) · Clover Biopharmaceuticals AUS Pty (3) · Enanta Pharmaceuticals, Inc (3)
United States (159) · China (48) · Australia (27) · Belgium (19) · United Kingdom (18) · Russia (15) · Canada (14) · Brazil (12) · France (12) · Germany (11) · South Korea (11) · South Africa (10) · Spain (10) · Japan (9) · Mexico (8)
Yao Zhang (3) · Elizabeth Martin, DO (2) · Fengcai Zhu, Doctor (2) · Johan Ursing, MD, PhD (2) · Marylyn M Addo, MD (2) · Mikhail Samsonov (2)
PMID 34473343, PMID 35713300, PMID 37231296, PMID 36147329, PMID 36435633, PMID 32896291, PMID 34551869, PMID 34890537, PMID 35316221, PMID 35547849, PMID 35660738, PMID 37354048, PMID 38181791, PMID 39749328, PMID 40632654, PMID 110688, PMID 11440640, PMID 15774846, PMID 15882530, PMID 16011702, PMID 16051812, PMID 16625202, PMID 17391816, PMID 17954801, PMID 18073382, PMID 18778201, PMID 19355966, PMID 19420084, PMID 19564349, PMID 20038196, PMID 20389020, PMID 20549206, PMID 20615924, PMID 21467219, PMID 22065672, PMID 22086194, PMID 22379685, PMID 22497915, PMID 23032745, PMID 23123106, PMID 23131206, PMID 23153437, PMID 25424847, PMID 25525182, PMID 26143615, PMID 26564103, PMID 26870818, PMID 27344959, PMID 27893465, PMID 27956136
2023 (3), 5UM1AI148373-05 (2), 5UM1AI148684-02 (2), 2009 (1), 2015 (1), 2018 (1), 2025 (1), P30CA033572 (1), P30CA047904 (1), R21DC014567 (1), R44HL066965 (1)